Search

Makredes, Maryanne, Don Robinson, Mohan Bala, and Alexa B Kimball. 2009. “The Burden of Autoimmune Disease: A Comparison of Prevalence Ratios in Patients With Psoriatic Arthritis and Psoriasis.”. Journal of the American Academy of Dermatology 61 (3): 405-10.

Kimball, A B, D Robinson, Y Wu, C Guzzo, N Yeilding, C Paramore, K Fraeman, and M Bala. 2008. “Cardiovascular Disease and Risk Factors Among Psoriasis Patients in Two US Healthcare Databases, 2001-2002.”. Dermatology (Basel, Switzerland) 217 (1): 27-37.

Ciocon, David H, Elizabeth J Horn, and Alexa B Kimball. 2008. “Quality of Life and Treatment Satisfaction Among Patients With Psoriasis and Psoriatic Arthritis and Patients With Psoriasis only : Results of the 2005 Spring US National Psoriasis Foundation Survey.”. American Journal of Clinical Dermatology 9 (2): 111-7.

Lebwohl, Mark, Jerry Bagel, Joel M Gelfand, Dafna Gladman, Kenneth B Gordon, Sylvia Hsu, Robert E Kalb, et al. 2008. “From the Medical Board of the National Psoriasis Foundation: Monitoring and Vaccinations in Patients Treated With Biologics for Psoriasis.”. Journal of the American Academy of Dermatology 58 (1): 94-105.

Revicki, Dennis A, Mary Kaye Willian, Alan Menter, Kenneth B Gordon, Alexa B Kimball, Craig L Leonardi, Richard G Langley, Miriam Kimel, and Martin Okun. 2007. “Impact of Adalimumab Treatment on Patient-Reported Outcomes: Results from a Phase III Clinical Trial in Patients With Moderate to Severe Plaque Psoriasis.”. The Journal of Dermatological Treatment 18 (6): 341-50.

Marchetti, Albert, Steven R Feldman, Alexandra Boer Kimball, Richard Rox Anderson, Laurence H Miller, John Martin, and Peter An. 2005. “Treatments for Mild-to-Moderate Recalcitrant Plaque Psoriasis: Expected Clinical and Economic Outcomes for First-Line and Second-Line Care.”. Dermatology Online Journal 11 (1): 1.

Papp, Kim A, Bruce Strober, Matthias Augustin, Steve Calabro, Anil Londhe, Marc Chevrier, and PSOLAR investigators and Steering Committee. 2012. “PSOLAR: Design, Utility, and Preliminary Results of a Prospective, International, Disease-Based Registry of Patients With Psoriasis Who Are Receiving, or Are Candidates For, Conventional Systemic Treatments or Biologic Agents.”. Journal of Drugs in Dermatology : JDD 11 (10): 1210-7.

Bae, Yoon-Soo Cindy, Abby S Van Voorhees, Sylvia Hsu, Neil J Korman, Mark G Lebwohl, Melody Young, Bruce Bebo, Alexa Boer Kimball, and National Psoriasis Foundation. 2012. “Review of Treatment Options for Psoriasis in Pregnant or Lactating Women: From the Medical Board of the National Psoriasis Foundation.”. Journal of the American Academy of Dermatology 67 (3): 459-77.

Robinson, Amanda, Marisa Kardos, and Alexandra B Kimball. 2012. “Physician Global Assessment (PGA) and Psoriasis Area and Severity Index (PASI): Why Do Both? A Systematic Analysis of Randomized Controlled Trials of Biologic Agents for Moderate to Severe Plaque Psoriasis.”. Journal of the American Academy of Dermatology 66 (3): 369-75.

Kimball, Alexa Boer, Andrew P Yu, James Signorovitch, Jipan Xie, Magda Tsaneva, Shiraz R Gupta, Yanjun Bao, and Parvez M Mulani. 2012. “The Effects of Adalimumab Treatment and Psoriasis Severity on Self-Reported Work Productivity and Activity Impairment for Patients With Moderate to Severe Psoriasis.”. Journal of the American Academy of Dermatology 66 (2): e67-76.